704 related articles for article (PubMed ID: 32132110)
21. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
[TBL] [Abstract][Full Text] [Related]
22. Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids.
Pfeffer BA; DeWitt CA; Salvador-Silva M; Cavet ME; López FJ; Ward KW
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):437-46. PubMed ID: 19696178
[TBL] [Abstract][Full Text] [Related]
23. Activin A Causes Muscle Atrophy through MEF2C-Dependent Impaired Myogenesis.
Loumaye A; Lause P; Zhong X; Zimmers TA; Bindels LB; Thissen JP
Cells; 2022 Mar; 11(7):. PubMed ID: 35406681
[TBL] [Abstract][Full Text] [Related]
24. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia.
Mulder SE; Dasgupta A; King RJ; Abrego J; Attri KS; Murthy D; Shukla SK; Singh PK
Cancer Lett; 2020 Oct; 491():70-77. PubMed ID: 32735910
[TBL] [Abstract][Full Text] [Related]
25. STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.
Bonetto A; Aydogdu T; Kunzevitzky N; Guttridge DC; Khuri S; Koniaris LG; Zimmers TA
PLoS One; 2011; 6(7):e22538. PubMed ID: 21799891
[TBL] [Abstract][Full Text] [Related]
26. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia.
Shukla SK; Markov SD; Attri KS; Vernucci E; King RJ; Dasgupta A; Grandgenett PM; Hollingsworth MA; Singh PK; Yu F; Mehla K
Cancer Lett; 2020 Aug; 484():29-39. PubMed ID: 32344015
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia.
Conte E; Camerino GM; Mele A; De Bellis M; Pierno S; Rana F; Fonzino A; Caloiero R; Rizzi L; Bresciani E; Ben Haj Salah K; Fehrentz JA; Martinez J; Giustino A; Mariggiò MA; Coluccia M; Tricarico D; Lograno MD; De Luca A; Torsello A; Conte D; Liantonio A
J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):386-404. PubMed ID: 28294567
[TBL] [Abstract][Full Text] [Related]
28. MyD88 signalling is critical in the development of pancreatic cancer cachexia.
Zhu X; Burfeind KG; Michaelis KA; Braun TP; Olson B; Pelz KR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):378-390. PubMed ID: 30666818
[TBL] [Abstract][Full Text] [Related]
29. The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders.
Koopman R; Ryall JG; Church JE; Lynch GS
Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):601-6. PubMed ID: 19741516
[TBL] [Abstract][Full Text] [Related]
30. Disrupted NOS2 metabolism drives myoblast response to wasting-associated cytokines.
Arneson-Wissink PC; Doles JD
Exp Cell Res; 2021 Oct; 407(1):112779. PubMed ID: 34428455
[TBL] [Abstract][Full Text] [Related]
31. Aerobic Exercise Ameliorates Cancer Cachexia-Induced Muscle Wasting through Adiponectin Signaling.
Morinaga M; Sako N; Isobe M; Lee-Hotta S; Sugiura H; Kametaka S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803685
[TBL] [Abstract][Full Text] [Related]
32. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
[TBL] [Abstract][Full Text] [Related]
33. NFATc1 activity regulates the expression of myocilin induced by dexamethasone.
Faralli JA; Clark RW; Filla MS; Peters DM
Exp Eye Res; 2015 Jan; 130():9-16. PubMed ID: 25450062
[TBL] [Abstract][Full Text] [Related]
34. Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation.
Costelli P; Muscaritoli M; Bossola M; Moore-Carrasco R; Crepaldi S; Grieco G; Autelli R; Bonelli G; Pacelli F; Lopez-Soriano FJ; Argilés JM; Doglietto GB; Baccino FM; Rossi Fanelli F
Int J Oncol; 2005 Jun; 26(6):1663-8. PubMed ID: 15870883
[TBL] [Abstract][Full Text] [Related]
35. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
[TBL] [Abstract][Full Text] [Related]
36. NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia.
He WA; Berardi E; Cardillo VM; Acharyya S; Aulino P; Thomas-Ahner J; Wang J; Bloomston M; Muscarella P; Nau P; Shah N; Butchbach ME; Ladner K; Adamo S; Rudnicki MA; Keller C; Coletti D; Montanaro F; Guttridge DC
J Clin Invest; 2013 Nov; 123(11):4821-35. PubMed ID: 24084740
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial plasticity in cancer-related muscle wasting: potential approaches for its management.
Vitorino R; Moreira-Gonçalves D; Ferreira R
Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):226-33. PubMed ID: 25783794
[TBL] [Abstract][Full Text] [Related]
38. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.
Acharyya S; Ladner KJ; Nelsen LL; Damrauer J; Reiser PJ; Swoap S; Guttridge DC
J Clin Invest; 2004 Aug; 114(3):370-8. PubMed ID: 15286803
[TBL] [Abstract][Full Text] [Related]
39. Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3.
Chen L; Xu W; Yang Q; Zhang H; Wan L; Xin B; Zhang J; Guo C
Pharmacol Res; 2020 Aug; 158():104871. PubMed ID: 32413482
[TBL] [Abstract][Full Text] [Related]
40. Muscle wasting in cancer: the role of mitochondria.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):221-5. PubMed ID: 25769061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]